Atish Kizhakeyil

ORCID: 0000-0003-1686-6063
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune Cell Function and Interaction
  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • T-cell and B-cell Immunology
  • Cell Adhesion Molecules Research
  • Bone Tissue Engineering Materials
  • Eosinophilic Disorders and Syndromes
  • Immune Response and Inflammation
  • Histone Deacetylase Inhibitors Research
  • Immunotherapy and Immune Responses
  • Cutaneous lymphoproliferative disorders research
  • RNA Research and Splicing
  • Ubiquitin and proteasome pathways
  • interferon and immune responses
  • Peptidase Inhibition and Analysis
  • Epigenetics and DNA Methylation
  • Antimicrobial Peptides and Activities
  • Cellular transport and secretion
  • RNA Interference and Gene Delivery
  • Luminescence and Fluorescent Materials
  • Ferrocene Chemistry and Applications
  • Advancements in Semiconductor Devices and Circuit Design
  • Titanium Alloys Microstructure and Properties
  • Monoclonal and Polyclonal Antibodies Research
  • Advanced Drug Delivery Systems

The University of Texas MD Anderson Cancer Center
2022-2024

Nanyang Technological University
2016-2022

Indian Institute of Technology Bombay
2021

A new drug concentration meter is developed. In vivo release can be monitored precisely via a self-indicating delivery system consisting of aggregation-induced emission thermoresponsive hydrogel. By taking the advantage system, one easily detect depletion drugs, and reinject to maintain dosage in optimal therapeutic window. As service our authors readers, this journal provides supporting information supplied by authors. Such materials are peer reviewed may re-organized for online delivery,...

10.1002/smll.201603404 article EN Small 2016-12-08

SMARCA4 encodes one of two mutually exclusive ATPase subunits in the BRG/BRM associated factor (BAF) complex that is recruited by transcription factors (TFs) to drive chromatin accessibility and transcriptional activation. among most recurrently mutated genes human cancer, including ∼30% germinal center (GC)-derived Burkitt lymphomas. In mice, GC-specific Smarca4 haploinsufficiency cooperated with MYC over-expression lymphomagenesis. Furthermore, monoallelic deletion drove GC hyperplasia...

10.1016/j.ccell.2024.02.011 article EN cc-by-nc-nd Cancer Cell 2024-03-07

Abstract In this study, we report that the integrin LFA-1 cross-linking with its ligand ICAM-1 in human PBMCs or CD4+ T cells promotes Th1 polarization by upregulating IFN-γ secretion and T-bet expression. stimulation PBMCs, cells, cell line HuT78 activates Notch pathway nuclear translocation of cleaved Notch1 intracellular domain (NICD) upregulation target molecules Hey1 Hes1. Blocking a neutralizing Ab specific inhibition γ-secretase inhibitor substantially inhibits LFA-1/ICAM-1–mediated...

10.4049/jimmunol.1501264 article EN The Journal of Immunology 2016-05-23

Abstract Post-transcriptional gene silencing holds great promise in discovery research for addressing intricate biological questions and as therapeutics. While various approaches, such siRNA CRISPR-Cas9 techniques, are available, these cannot be effectively applied to “hard-to-transfect” primary T-lymphocytes. The locked nucleic acid-conjugated chimeric antisense oligonucleotide, called “GapmeR”, is an emerging new class of molecule. Here, we show that GapmeR internalizes into human T-cells...

10.1038/srep37721 article EN cc-by Scientific Reports 2016-11-24

Recent studies have described the remarkable clinical outcome of anti-CD19 chimeric antigen receptor (CAR) T cells in treating B-cell malignancies. However, over 50% patients develop life-threatening toxicities associated with cytokine release syndrome which may limit its utilization low-resource settings. To mitigate toxicity, we designed a novel humanized CAR by humanizing framework region single-chain variable fragment (scFv) derived from murine FMC63 mAb and combining it CD8α...

10.1158/1535-7163.mct-20-0476 article EN Molecular Cancer Therapeutics 2021-02-25

CG-NAP, also known as AKAP450, is a cytosolic scaffolding protein involved in the targeted positioning of multiple signaling molecules, which are critical for cellular functioning. Here, we show that CG-NAP predominantly expressed human primary T-lymphocytes, localizes close proximity (<0.2 μm) with centrosomal and Golgi structures serves docking platform Protein Kinase A (PKA). GapmeR-mediated knockdown inhibits LFA-1-induced T-cell migration impairs chemotaxis towards chemokine SDF-1α....

10.3389/fimmu.2018.00397 article EN cc-by Frontiers in Immunology 2018-03-01

Background: Hesperetin is a natural compound known for its cholesterol-lowering effect and wide range of pharmacological activities. Objectives: Investigating the potential anticancer activities in malignant hematolymphoid cell lines HuT78 MJ, derived from patients with Cutaneous T-Cell Lymphomas (CTCL). Methods: The cytotoxic on two different CTCL lines, was assessed by MTS-based colorimetric assay. Apoptosis, cycle, ROS (Reactive Oxygen Species) molecular analysis were performed using...

10.2174/1871521409666200324110031 article EN Anti-Cancer Agents in Medicinal Chemistry 2020-03-24

Host defense peptides represent an important component of innate immunity. In this work, we report the anticancer properties a panel hyper-charged wholly cationic antimicrobial dodecapeptides (CAPs) containing multiple canonical forms lysine and arginine residues. These CAPs displayed excellent bactericidal activities against broad range pathogenic bacteria by dissipating cytoplasmic membrane potential. Specifically, identified two CAPs, named HC3 HC5, that effectively killed significant...

10.3390/pharmaceutics14112507 article EN cc-by Pharmaceutics 2022-11-18

The development of new organometallic compounds as anticancer agents is currently an active area research. Here, we report the design, synthesis and characterization a panel 10 ferrocenyl-phosphine derivatives (FD1-FD10) analysis their anti-proliferative activities in hematolymphoid cells representing non-Hodgkin cutaneous T-cell lymphoma (CTCL). gold-coordinated complex FD10 exhibited significant dose-dependent cytotoxicity 4 different CTCL cell lines - HuT78, HH, MJ MyLa. concentrations...

10.1039/c8ra05224g article EN cc-by-nc RSC Advances 2018-01-01

In article number 1603404, Yun-Long Wu, Xian Jun Loh, and co-workers have created a self-indicating hydrogel that instantly reveals real-time drug concentration in the hydrogel. The gel shows potential as meter to benefit experimental non-invasive monitoring of actual release profile, which is not effectively supported by current technologies materials.

10.1002/smll.201770042 article EN Small 2017-02-01

Abstract Non-Hodgkin’s lymphoma (NHL) is a diverse group of malignancies, encompassing the most common diffuse large B-cell (DLBCL) to rarer T-cell lymphomas. DDX3X an RNA helicase and, depending on tumour type, plays suppressive or oncogenic roles in cancer. However, its role NHL not clear. Targeted sequencing hotspots exons 8-15 cohort 158 unselected DLBCL subjects showed mutations 5 cases; whereas whole exome 9 relapsed/refractory patients treated with R-CHOP identified 4 cases. (n=223)...

10.21203/rs.3.rs-209388/v1 preprint EN cc-by Research Square (Research Square) 2021-03-09
Coming Soon ...